A detailed history of Lri Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Lri Investments, LLC holds 4,734 shares of NVS stock, worth $493,661. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,734
Previous 2,168 118.36%
Holding current value
$493,661
Previous $231 Million 112.08%
% of portfolio
0.05%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$106.13 - $120.89 $272,329 - $310,203
2,566 Added 118.36%
4,734 $490 Million
Q2 2024

Jul 24, 2024

BUY
$92.57 - $107.37 $185,140 - $214,740
2,000 Added 1190.48%
2,168 $231 Million
Q1 2024

May 21, 2024

SELL
$95.27 - $108.47 $190,540 - $216,940
-2,000 Reduced 92.25%
168 $16.3 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $206,545 - $235,162
2,168 New
2,168 $222 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.